CMS ASSISTS ASIT BIOTECH IN ITS NEW FUNDRAISING
CMS Belgium assisted ASIT biotech in the preparation of its new fundraising in order to further develop its activities. ASIT biotech is a Belgian clinical-stage biopharmaceutical company listed on Euronext Paris and Euronext Brussels, focusing on the research of breakthrough immunotherapy products for the treatment of allergies.